日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ctDNA guided immunotherapy in patients with advanced non-small cell lung cancer: a nationwide Danish, randomised, intervention study (PRELUCA-PRediction in LUng CAncer Treatment) - study protocol

ctDNA指导的免疫疗法治疗晚期非小细胞肺癌患者:一项丹麦全国性随机干预研究(PRELUCA-PRediction in LUNG CAncere Treatment)——研究方案

Andersen, Michael Elmkvist; Nyhus, Christa Haugaard; Szejniuk, Weronika Maria; Wahlstrøm, Stine; Timm, Signe; Pallisgaard, Niels; Madsen, Malene Green; Mikkelsen, Maria Dalgaard; Ahlborn, Lise Barlebo; Gehl, Julie; Frank, Malene Støchkel

Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy.

可溶性程序性死亡配体 1 作为接受纳武利尤单抗、帕博利珠单抗或阿特珠单抗治疗的非小细胞肺癌患者的预后生物标志物

Brun Sinne Søberg, Hansen Torben Frøstrup, Wen Sara Witting Christensen, Nyhus Christa Haugaard, Bertelsen Lisbeth, Jakobsen Anders, Hansen Torben Schjødt, Nederby Line

NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

NK细胞活性和甲基化HOXA9 ctDNA作为PD-1/PD-L1抑制剂治疗的非小细胞肺癌患者的预后生物标志物

Wen, Sara Witting Christensen; Nederby, Line; Andersen, Rikke Fredslund; Hansen, Torben Schjødt; Nyhus, Christa Haugaard; Hilberg, Ole; Jakobsen, Anders; Hansen, Torben Frøstrup

The prognostic impact of circulating homeobox A9 methylated DNA in advanced non-small cell lung cancer

循环同源框A9甲基化DNA在晚期非小细胞肺癌中的预后影响

Wen, Sara Witting Christensen; Andersen, Rikke Fredslund; Hansen, Torben Frøstrup; Nyhus, Christa Haugaard; Hager, Henrik; Hilberg, Ole; Jakobsen, Anders